Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
The future of incretins in the treatment of obesity and non-alcoholic fatty liver diseaseDiabetologia 2023 Oct 01;66(10)1846-1858, CR Andreasen, A Andersen, T Vilsbøll
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.